Zhu Z, Olson K, Magliery T
Antibodies (Basel). 2024; 13(4).
PMID: 39727482
PMC: 11672675.
DOI: 10.3390/antib13040099.
Stagg S, Yoshioka C, Davulcu O, Chapman M
Chem Rev. 2022; 122(17):14018-14054.
PMID: 35575684
PMC: 9479082.
DOI: 10.1021/acs.chemrev.1c00936.
Vishwakarma P, Vattekatte A, Shinada N, Diharce J, Martins C, Cadet F
Int J Mol Sci. 2022; 23(7).
PMID: 35409081
PMC: 8998791.
DOI: 10.3390/ijms23073721.
Di Rienzo L, Milanetti E, Ruocco G, Lepore R
Front Mol Biosci. 2021; 8:749784.
PMID: 34660699
PMC: 8514621.
DOI: 10.3389/fmolb.2021.749784.
Liang T, Chen H, Yuan J, Jiang C, Hao Y, Wang Y
Brief Bioinform. 2021; 22(5).
PMID: 33876197
PMC: 8579189.
DOI: 10.1093/bib/bbab143.
Solubility, Stability, and Avidity of Recombinant Antibody Fragments Expressed in Microorganisms.
Kang T, Seong B
Front Microbiol. 2020; 11:1927.
PMID: 33101218
PMC: 7546209.
DOI: 10.3389/fmicb.2020.01927.
Biomedical Science to Tackle the COVID-19 Pandemic: Current Status and Future Perspectives.
Zamora-Ledezma C, C D, Medina E, Sinche F, Vispo N, Dahoumane S
Molecules. 2020; 25(20).
PMID: 33050601
PMC: 7587204.
DOI: 10.3390/molecules25204620.
How repertoire data are changing antibody science.
Marks C, Deane C
J Biol Chem. 2020; 295(29):9823-9837.
PMID: 32409582
PMC: 7380193.
DOI: 10.1074/jbc.REV120.010181.
Computational approaches to therapeutic antibody design: established methods and emerging trends.
Norman R, Ambrosetti F, Bonvin A, Colwell L, Kelm S, Kumar S
Brief Bioinform. 2019; 21(5):1549-1567.
PMID: 31626279
PMC: 7947987.
DOI: 10.1093/bib/bbz095.
In Silico Methods in Antibody Design.
Zhao J, Nussinov R, Wu W, Ma B
Antibodies (Basel). 2019; 7(3).
PMID: 31544874
PMC: 6640671.
DOI: 10.3390/antib7030022.
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.
Rasetti-Escargueil C, Avril A, Miethe S, Mazuet C, Derman Y, Selby K
Toxins (Basel). 2017; 9(10).
PMID: 28974033
PMC: 5666356.
DOI: 10.3390/toxins9100309.
A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6.
Robert R, Juglair L, Lim E, Ang C, Wang C, Ebert G
PLoS One. 2017; 12(9):e0184278.
PMID: 28873441
PMC: 5584921.
DOI: 10.1371/journal.pone.0184278.
De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
Entzminger K, Hyun J, Pantazes R, Patterson-Orazem A, Qerqez A, Frye Z
Sci Rep. 2017; 7(1):10295.
PMID: 28860479
PMC: 5579192.
DOI: 10.1038/s41598-017-10737-9.
PIGSPro: prediction of immunoGlobulin structures v2.
Lepore R, Olimpieri P, Messih M, Tramontano A
Nucleic Acids Res. 2017; 45(W1):W17-W23.
PMID: 28472367
PMC: 5570210.
DOI: 10.1093/nar/gkx334.
Sphinx: merging knowledge-based and ab initio approaches to improve protein loop prediction.
Marks C, Nowak J, Klostermann S, Georges G, Dunbar J, Shi J
Bioinformatics. 2017; 33(9):1346-1353.
PMID: 28453681
PMC: 5408792.
DOI: 10.1093/bioinformatics/btw823.
Antibody H3 Structure Prediction.
Marks C, Deane C
Comput Struct Biotechnol J. 2017; 15:222-231.
PMID: 28228926
PMC: 5312500.
DOI: 10.1016/j.csbj.2017.01.010.
Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays.
Gerdtsson A, Dexlin-Mellby L, Delfani P, Berglund E, Borrebaeck C, Wingren C
Microarrays (Basel). 2016; 5(2).
PMID: 27600082
PMC: 5003492.
DOI: 10.3390/microarrays5020016.
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A
PLoS One. 2016; 11(8):e0161446.
PMID: 27560688
PMC: 4999263.
DOI: 10.1371/journal.pone.0161446.
Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus.
Organtini L, Lee H, Iketani S, Huang K, Ashley R, Makhov A
J Virol. 2016; 90(21):9733-9742.
PMID: 27535057
PMC: 5068525.
DOI: 10.1128/JVI.01112-16.
Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints.
Finn J, Leman J, Willis J, Cisneros 3rd A, Crowe Jr J, Meiler J
PLoS One. 2016; 11(5):e0154811.
PMID: 27182833
PMC: 4868311.
DOI: 10.1371/journal.pone.0154811.